SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-054447
Filing Date
2018-10-05
Accepted
2018-10-05 18:48:40
Documents
2
Period of Report
2018-09-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1672
2 POA DOCUMENT poa.txt EX-24.3_812992 4244
  Complete submission text file 0001209191-18-054447.txt   7215
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Issuer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address
Hogenhuis Wladimir (Reporting) CIK: 0001755074 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36276 | Film No.: 181111619